Brennan H. Baker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Brennan H. Baker has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
Sheela Sathyanarayana
University of Washington, Seattle, WA, 98195, USA; Seattle Children's Research Institute, 1920 Terry Avenue, Seattle, WA, 98101, USA
8 shared publicationsAlison G. Paquette
University of Washington, Seattle, USA
6 shared publicationsNicole R. Bush
University of California, San Francisco, San Francisco, CA, 94143, USA
5 shared publicationsQi Zhao
University of Tennessee Health Science Center, Memphis, USA
5 shared publicationsEmily S. Barrett
Rutgers School of Public Health, Piscataway, NJ, 08854, USA
4 shared publicationsJames W. MacDonald
University of Washington, Seattle, USA
4 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 211, 113001
Joint and independent associations of maternal childhood trauma and prenatal stress with child respiratory outcomes
- 22 September 2026
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 211, 113001
Open AccessJoint and independent associations of maternal childhood trauma and prenatal stress with child respiratory outcomes
- Open Access
- 21 May 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (8) , 2158-2169
Prenatal over-the-counter acetaminophen use and birth outcomes in the ECHO Cohort
Acetaminophen is among the most common over-the-counter medications used during pregnancy. Given inconsistent findings from both experimental and epidemiological studies on associations between use and adverse health outcomes, further research is warranted. To address this, our objective was to assess the relationship between prenatal acetaminophen use and birth outcomes. We studied 8957 mother–infant pairs from 36 pediatric study sites participating in the Environmental influences on Child Health Outcomes (ECHO) program. After imputation and inverse probability weighting, we used regression models to examine the relationship between acetaminophen during pregnancy and the following outcomes: (1) preterm birth, (2) birthweight, (3) small-for-gestational age (SGA), and (4) large-for-gestational-age (LGA). Approximately 59% of mothers reported using acetaminophen at any point during their pregnancy (n = 5257). After adjustment for relevant covariates, prenatal acetaminophen use was associated with lower odds of LGA (adjusted odds ratio [aOR]: 0.87; 95% CI: 0.79, 0.96). Prenatal acetaminophen use was not associated with preterm birth (aOR: 0.99; 95% CI: 0.86, 1.14), birthweight (aβ: −7.52 g; 95% CI: −27.80, 12.77) or SGA (aOR: 1.02; 95% CI: 0.88, 1.18). Based on these findings, future research should test for dose–response, trimester-specific exposures, and factors affecting individual responses.
- 21 May 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (8) , 2158-2169
Open AccessPrenatal over-the-counter acetaminophen use and birth outcomes in the ECHO Cohort
Acetaminophen is among the most common over-the-counter medications used during pregnancy. Given inconsistent findings from both experimental and epidemiological studies on associations between use and adverse health outcomes, further research is warranted. To address this, our objective was to assess the relationship between prenatal acetaminophen use and birth outcomes. We studied 8957 mother–infant pairs from 36 pediatric study sites participating in the Environmental influences on Child Health Outcomes (ECHO) program. After imputation and inverse probability weighting, we used regression models to examine the relationship between acetaminophen during pregnancy and the following outcomes: (1) preterm birth, (2) birthweight, (3) small-for-gestational age (SGA), and (4) large-for-gestational-age (LGA). Approximately 59% of mothers reported using acetaminophen at any point during their pregnancy (n = 5257). After adjustment for relevant covariates, prenatal acetaminophen use was associated with lower odds of LGA (adjusted odds ratio [aOR]: 0.87; 95% CI: 0.79, 0.96). Prenatal acetaminophen use was not associated with preterm birth (aOR: 0.99; 95% CI: 0.86, 1.14), birthweight (aβ: −7.52 g; 95% CI: −27.80, 12.77) or SGA (aOR: 1.02; 95% CI: 0.88, 1.18). Based on these findings, future research should test for dose–response, trimester-specific exposures, and factors affecting individual responses.
- Open Access
- 3 March 2026
- Published by Elsevier in JAACAP Open
- Vol. 4 (3) , 488-497
Perceived Stress During Pregnancy and Offspring Attention-Deficit/Hyperactivity Disorder: Findings From the ECHO Cohort Study
- 3 March 2026
- Published by Elsevier in JAACAP Open
- Vol. 4 (3) , 488-497
Open AccessPerceived Stress During Pregnancy and Offspring Attention-Deficit/Hyperactivity Disorder: Findings From the ECHO Cohort Study
- Open Access
- 11 December 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Placental proteomic signatures of preterm birth, gestational age, and birthweight
Preterm birth and low birthweight are leading contributors to infant morbidity and mortality, yet underlying mechanisms remain poorly understood. Proteomic
- 11 December 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessPlacental proteomic signatures of preterm birth, gestational age, and birthweight
Preterm birth and low birthweight are leading contributors to infant morbidity and mortality, yet underlying mechanisms remain poorly understood. Proteomic
- Open Access
- 25 November 2025
- Published by Elsevier in Environmental Pollution
- Vol. 389, 127441
Psychosocial stressors as modifiers of the associations between well-studied and understudied chemicals and birth outcomes in the ECHO Cohort
- 25 November 2025
- Published by Elsevier in Environmental Pollution
- Vol. 389, 127441
Open AccessPsychosocial stressors as modifiers of the associations between well-studied and understudied chemicals and birth outcomes in the ECHO Cohort
- 6 February 2025
- Published by Springer Nature in Nature Mental Health
- Vol. 3 (3) , 318-331
Associations of maternal blood biomarkers of prenatal APAP exposure with placental gene expression and child attention deficit hyperactivity disorder
Despite evidence linking prenatal acetaminophen (APAP) exposure and adverse neurodevelopment in humans and animals, over half of pregnant women in most populations use APAP. Prior studies could be biased by inaccurate self-reported APAP use, and the molecular mechanisms linking prenatal APAP with adverse neurodevelopment are unknown. Here we estimated associations between maternal plasma biomarkers of APAP exposure, child attention deficit hyperactivity disorder (ADHD) and placental gene expression in 307 African American mother–child pairs. Overall, detection of APAP in second trimester plasma was associated with higher odds for child ADHD diagnosis (odds ratio of 3.15 (95% confidence interval 1.20 to 8.29)). Prenatal APAP exposure and ADHD were associated with placental upregulation of immune system pathways in females and downregulation of oxidative phosphorylation in both sexes. In females only, prenatal APAP was associated with 5.22% higher odds (0.0456–13.1%) of ADHD statistically, mediated through increased immunoglobulin heavy constant gamma 1 (IGHG1) expression. These results highlight placental molecular mechanisms that may underlie developmental toxicity of prenatal APAP exposure.
- 6 February 2025
- Published by Springer Nature in Nature Mental Health
- Vol. 3 (3) , 318-331
Associations of maternal blood biomarkers of prenatal APAP exposure with placental gene expression and child attention deficit hyperactivity disorder
Despite evidence linking prenatal acetaminophen (APAP) exposure and adverse neurodevelopment in humans and animals, over half of pregnant women in most populations use APAP. Prior studies could be biased by inaccurate self-reported APAP use, and the molecular mechanisms linking prenatal APAP with adverse neurodevelopment are unknown. Here we estimated associations between maternal plasma biomarkers of APAP exposure, child attention deficit hyperactivity disorder (ADHD) and placental gene expression in 307 African American mother–child pairs. Overall, detection of APAP in second trimester plasma was associated with higher odds for child ADHD diagnosis (odds ratio of 3.15 (95% confidence interval 1.20 to 8.29)). Prenatal APAP exposure and ADHD were associated with placental upregulation of immune system pathways in females and downregulation of oxidative phosphorylation in both sexes. In females only, prenatal APAP was associated with 5.22% higher odds (0.0456–13.1%) of ADHD statistically, mediated through increased immunoglobulin heavy constant gamma 1 (IGHG1) expression. These results highlight placental molecular mechanisms that may underlie developmental toxicity of prenatal APAP exposure.
- Open Access
- 3 September 2024
- Published by Springer Nature in Genome Biology
- Vol. 25 (1) , 1-25
RNAseqCovarImpute: a multiple imputation procedure that outperforms complete case and single imputation differential expression analysis
Missing covariate data is a common problem that has not been addressed in observational studies of gene expression. Here, we present a multiple imputation method that accommodates high dimensional gene expression data by incorporating principal component analysis of the transcriptome into the multiple imputation prediction models to avoid bias. Simulation studies using three datasets show that this method outperforms complete case and single imputation analyses at uncovering true positive differentially expressed genes, limiting false discovery rates, and minimizing bias. This method is easily implemented via an R Bioconductor package, RNAseqCovarImpute that integrates with the limma-voom pipeline for differential expression analysis.
- 3 September 2024
- Published by Springer Nature in Genome Biology
- Vol. 25 (1) , 1-25
Open AccessRNAseqCovarImpute: a multiple imputation procedure that outperforms complete case and single imputation differential expression analysis
Missing covariate data is a common problem that has not been addressed in observational studies of gene expression. Here, we present a multiple imputation method that accommodates high dimensional gene expression data by incorporating principal component analysis of the transcriptome into the multiple imputation prediction models to avoid bias. Simulation studies using three datasets show that this method outperforms complete case and single imputation analyses at uncovering true positive differentially expressed genes, limiting false discovery rates, and minimizing bias. This method is easily implemented via an R Bioconductor package, RNAseqCovarImpute that integrates with the limma-voom pipeline for differential expression analysis.
- 12 August 2024
- Published by Elsevier in Environmental Research
- Vol. 262 (Pt 1) , 119776
Associations of environmental chemical exposures measured in personal silicone wristbands with sociodemographic factors, COVID-19 restrictions, and child respiratory health
- 12 August 2024
- Published by Elsevier in Environmental Research
- Vol. 262 (Pt 1) , 119776
Associations of environmental chemical exposures measured in personal silicone wristbands with sociodemographic factors, COVID-19 restrictions, and child respiratory health
- Open Access
- 11 January 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (4) , 1179-1191
Placental transcriptomic signatures of prenatal and preconceptional maternal stress
Prenatal exposure to maternal psychological stress is associated with increased risk for adverse birth and child health outcomes. Accumulating evidence suggests that preconceptional maternal stress may also be transmitted intergenerationally to negatively impact offspring. However, understanding of mechanisms linking these exposures to offspring outcomes, particularly those related to placenta, is limited. Using RNA sequencing, we identified placental transcriptomic signatures associated with maternal prenatal stressful life events (SLEs) and childhood traumatic events (CTEs) in 1 029 mother-child pairs in two birth cohorts from Washington state and Memphis, Tennessee. We evaluated individual gene-SLE/CTE associations and performed an ensemble of gene set enrichment analyses combing across 11 popular enrichment methods. Higher number of prenatal SLEs was significantly (FDR < 0.05) associated with increased expression of ADGRG6, a placental tissue-specific gene critical in placental remodeling, and decreased expression of RAB11FIP3, an endocytosis and endocytic recycling gene, and SMYD5, a histone methyltransferase. Prenatal SLEs and maternal CTEs were associated with gene sets related to several biological pathways, including upregulation of protein processing in the endoplasmic reticulum, protein secretion, and ubiquitin mediated proteolysis, and down regulation of ribosome, epithelial mesenchymal transition, DNA repair, MYC targets, and amino acid-related pathways. The directional associations in these pathways corroborate prior non-transcriptomic mechanistic studies of psychological stress and mental health disorders, and have previously been implicated in pregnancy complications and adverse birth outcomes. Accordingly, our findings suggest that maternal exposure to psychosocial stressors during pregnancy as well as the mother’s childhood may disrupt placental function, which may ultimately contribute to adverse pregnancy, birth, and child health outcomes.
- 11 January 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (4) , 1179-1191
Open AccessPlacental transcriptomic signatures of prenatal and preconceptional maternal stress
Prenatal exposure to maternal psychological stress is associated with increased risk for adverse birth and child health outcomes. Accumulating evidence suggests that preconceptional maternal stress may also be transmitted intergenerationally to negatively impact offspring. However, understanding of mechanisms linking these exposures to offspring outcomes, particularly those related to placenta, is limited. Using RNA sequencing, we identified placental transcriptomic signatures associated with maternal prenatal stressful life events (SLEs) and childhood traumatic events (CTEs) in 1 029 mother-child pairs in two birth cohorts from Washington state and Memphis, Tennessee. We evaluated individual gene-SLE/CTE associations and performed an ensemble of gene set enrichment analyses combing across 11 popular enrichment methods. Higher number of prenatal SLEs was significantly (FDR < 0.05) associated with increased expression of ADGRG6, a placental tissue-specific gene critical in placental remodeling, and decreased expression of RAB11FIP3, an endocytosis and endocytic recycling gene, and SMYD5, a histone methyltransferase. Prenatal SLEs and maternal CTEs were associated with gene sets related to several biological pathways, including upregulation of protein processing in the endoplasmic reticulum, protein secretion, and ubiquitin mediated proteolysis, and down regulation of ribosome, epithelial mesenchymal transition, DNA repair, MYC targets, and amino acid-related pathways. The directional associations in these pathways corroborate prior non-transcriptomic mechanistic studies of psychological stress and mental health disorders, and have previously been implicated in pregnancy complications and adverse birth outcomes. Accordingly, our findings suggest that maternal exposure to psychosocial stressors during pregnancy as well as the mother’s childhood may disrupt placental function, which may ultimately contribute to adverse pregnancy, birth, and child health outcomes.